Страна: США
мова: англійська
Джерело: NLM (National Library of Medicine)
URSODIOL (UNII: 724L30Y2QR) (URSODIOL - UNII:724L30Y2QR)
Actavis Pharma, Inc.
URSODIOL
URSODIOL 300 mg
ORAL
PRESCRIPTION DRUG
- Actigall is indicated for patients with radiolucent, noncalcified gallbladder stones < 20 mm in greatest diameter in whom elective cholecystectomy would be undertaken except for the presence of increased surgical risk due to systemic disease, advanced age, idiosyncratic reaction to general anesthesia, or for those patients who refuse surgery. Safety of use of Actigall beyond 24 months is not established. - Actigall is indicated for the prevention of gallstone formation in obese patients experiencing rapid weight loss. - Actigall will not dissolve calcified cholesterol stones, radiopaque stones, or radiolucent bile pigment stones. Hence, patients with such stones are not candidates for Actigall therapy. - Patients with compelling reasons for cholecystectomy including unremitting acute cholecystitis, cholangitis, biliary obstruction, gallstone pancreatitis, or biliary-gastrointestinal fistula are not candidates for Actigall therapy. - Allergy to bile acids.
Actigall Capsules are opaque white and pink capsules imprinted “ACTIGALL” on one half and “300 mg” on the other half of the capsule in black. Bottles of 100 are supplied with child-resistant closures. (NDC 52544-930-01) Store at 20-25°C (68-77°F). [See USP controlled room temperature.] Dispense in a tight container (USP). Keep out of reach of children. Rx only For all medical inquiries contact: ACTAVIS Medical Communications Parsippany, NJ 07054 1-800-272-5525 Manufactured By: Watson Pharma Private Limited Verna, Salcette Goa 403 722 INDIA Distributed By: Actavis Pharma, Inc. Parsippany, NJ 07054 USA Content Updated: November 2014 174785-1
New Drug Application
ACTIGALL- URSODIOL CAPSULE ACTAVIS PHARMA, INC. ---------- ACTIGALL (URSODIOL, USP) CAPSULES CONTENT UPDATED: NOVEMBER 2014 RX ONLY 174785-1 PRESCRIBING INFORMATION SPECIAL NOTE GALLBLADDER STONE DISSOLUTION WITH ACTIGALL TREATMENT REQUIRES MONTHS OF THERAPY. COMPLETE DISSOLUTION DOES NOT OCCUR IN ALL PATIENTS AND RECURRENCE OF STONES WITHIN 5 YEARS HAS BEEN OBSERVED IN UP TO 50% OF PATIENTS WHO DO DISSOLVE THEIR STONES ON BILE ACID THERAPY. PATIENTS SHOULD BE CAREFULLY SELECTED FOR THERAPY WITH URSODIOL, AND ALTERNATIVE THERAPIES SHOULD BE CONSIDERED. DESCRIPTION Actigall is a bile acid available as 300 mg capsules suitable for oral administration. Actigall is ursodiol, USP (ursodeoxycholic acid), a naturally occurring bile acid found in small quantities in normal human bile and in the biles of certain other mammals. It is a bitter-tasting, white powder freely soluble in ethanol, methanol, and glacial acetic acid; sparingly soluble in chloroform; slightly soluble in ether; and insoluble in water. The chemical name for ursodiol is 3α,7β-Dihydroxy- 5β-cholan-24-oic acid (C H O ). Ursodiol, USP has a molecular weight of 392.57. Its structure is shown below: _Inactive Ingredients: _Colloidal silicon dioxide, magnesium stearate, and starch (corn). Gelatin capsules contain ferric oxide, gelatin, and titanium dioxide. The capsules are printed with edible ink containing black iron oxide. CLINICAL PHARMACOLOGY About 90% of a therapeutic dose of Actigall is absorbed in the small bowel after oral administration. After absorption, ursodiol enters the portal vein and undergoes efficient extraction from portal blood by the liver (i.e., there is a large “first-pass” effect) where it is conjugated with either glycine or taurine and is then secreted into the hepatic bile ducts. Ursodiol in bile is concentrated in the gallbladder and expelled into the duodenum in gallbladder bile via the cystic and common ducts by gallbladder contractions provoked by physiologic responses to eating. Only small quantities of ursodiol appear Прочитайте повний документ